I.V. Dressing Market Sales Size Share Forecast 2027

Posted by Tejas Agrawal on January 9th, 2020

Global I.V. Dressing Market – Dynamics

Rising incidences of infections such as central line associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and other infections are expected to boost growth of the I.V. dressing market over the forecast period. For instance, according to the data published in National Healthcare Safety Network Bloodstream Infection Surveillance in March 2018, around 30,000 CLABSI cases are reported every year in the U.S. CLABSI can prolong the hospital stay, which can increase the cost burden on patients and also may lead to mortality.

Furthermore, according to the International Society for Infectious Diseases, March 2018, around 250,000 cases of blood stream are reported every year in the U.S. among these, around 80,000 are catheter-related bloodstream infection (CRBSI), which occurs in intensive care units.

Global I.V. Dressing Market – Regional Insights

North America accounted for the largest market share in 2018, owing to launches and approvals of new I.V. dressing products in the region. For instance, in January 2016, Entrotech life sciences, a U.S.-based company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ChloraDerm dressing, which protects against multi-drug-resistant organisms and other catheter-related bloodstream infections. Moreover, in September 2016, Becton, Dickinson and Company and Vancive Medical Technologies entered into a collaboration to launch a line of ChloraShield I.V. dressings developed for vascular access dressing and enhancing patient care. Therefore, these factors are expected to boost growth of the global I.V. dressing market over the forecast period.

 

Request Sample Copy of this Report:

https://www.coherentmarketinsights.com/insight/request-sample/3182

Global I.V. Dressing Market – Competitive Landscape

Key players operating in the global I.V. dressing market include Medline Industries, 3M, Paul Hartmann AG, Deroyal, Tytex Inc., Reliamed, Acelity, BSN Medical, CareFusion, Lohmann & Rauscher, Smith & Nephew, Shandong Dermcosy Medical Co.,Ltd., Talent Health Care, Datt Mediproducts Private Limited, and Others.

Moreover, key players in the market are focused on developing new products, in order to enhance their market share. For instance, in 2015, 3M launched Tegaderm CHG Chlorhexidine Gluconate I.V. port dressing for the patients with port devices under the skin, who are connected to catheter for central venous infusion.

Download PDF Brochure

https://www.coherentmarketinsights.com/insight/request-pdf/3182

Global I.V. Dressing Market - Taxonomy

On the basis of product type, the global I.V. dressing market is segmented into:

  • Transparent

  • Translucent

On the basis of use, the global I.V. dressing market is segmented into:

  • Reusable

  • Disposable

On the basis of end user, the global I.V. dressing market is segmented into:

  • Hospitals

  • Clinics

  • Others

On the basis of region, the global I.V. dressing market is segmented into:

  • North America

  • Latin America

  • Europe

  • Asia Pacific

  • Middle East

  • Africa

Get More Information On This Report: https://www.coherentmarketinsights.com/ongoing-insight/iv-dressing-market-3182

About us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Name: Mr. Raj Shah

Phone: US +12067016702 / UK +4402081334027

Email: sales@coherentmarketinsights.com

Visit our Blog: https://hospitalhealthcareblog.wordpress.com/

Like it? Share it!


Tejas Agrawal

About the Author

Tejas Agrawal
Joined: January 7th, 2020
Articles Posted: 9

More by this author